NCT00418548View on ClinicalTrials.gov

Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis

PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

February 28, 2005

Conditions
Ankylosing Spondylitis
Interventions
DRUG

Etanercept

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00418548 - Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter